Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,65
KB0,06
PKN67,467,430,93
Msft409,83409,882,70
Nokia3,38053,44951,09
IBM167,49167,5-0,85
Mercedes-Benz Group AG74,3674,381,56
PFE25,4925,50,95
26.04.2024 19:55:46
Indexy online
AD Index online
select
AD Index online
 

  • 26.04.2024 19:53:44
Merit Medic Sys (MMSI.O, NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
74,03 0,89 0,65 102 168
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 26.04.2024
Popis společnosti
Obecné informace
Název společnostiMerit Medical Systems Inc
TickerMMSI
Kmenové akcie:Ordinary Shares
RICMMSI.O
ISIN-
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2023 6 950
Akcie v oběhu k 18.03.2024 58 064 556
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
Ulice1600 West Merit Park Way
MěstoSOUTH JORDAN
PSČ84095
ZeměUnited States
Kontatní osobaMike Piccinino
Funkce kontaktní osobyIR Contact Officer
Telefon18 012 531 600
Fax18012531652
Kontatní telefon14 432 130 509

Business Summary: Merit Medical Systems, Inc. designs, develops, manufactures, markets and sells medical products for interventional and diagnostic procedures. The Company is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions and original equipment manufacturer. Within these product categories, it sells a variety of products, including cardiology and radiology devices, as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care and others. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Merit Medical Systems Inc revenues increased 9% to $1.26B. Net income increased 27% to $94.4M. Revenues reflect Cardiovascular segment increase of 9% to $1.22B, Endoscopy segment increase of 12% to $36.8M, International segment increase of 6% to $530.4M. Net income benefited from Cardiovascular segment income increase of 41% to $114.4M, Endoscopy segment income increase of 44% to $9.5M.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSMedical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS2007Electromedical Apparatus Mfg
NAICS2007Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Medical, Dental and Hospital Equipment and Supplies Wholesalers
SICSurgical And Medical Instruments
SICSurgical And Medical Instruments
SICCommercial Physical Research
SICElectromedical Equipment
SICMedical And Hospital Equipment



  • Poslední aktualizace: 26.04.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerFred Lampropoulos73
Chief Financial Officer, TreasurerRaul Parra4521.07.201829.05.2018
Chief Operating OfficerNeil Peterson5719.04.202219.04.2022
Chief Human Resource OfficerMichel Voigt50
Chief Commercial OfficerJoseph Wright5301.11.2022
Chief Legal Officer, Corporate SecretaryBrian Lloyd62